Protective effect of chlorogenic acid on renal ischemia/reperfusion injury in rats. 2020

Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
Fatih Sultan Mehmet Training and Research Hospital, Urology, Istanbul. drtuncay55@hotmail.com.

OBJECTIVE Ischemia/reperfusion (I/R) injury is a common cause of renal injury and to date, many pharmacological agents have been identified to decrease I/R injury. One of the potential compound that can target I/R injury is chlorogenic acid (CGA). It has potent antiinflammatory, antibacterial, anti-oxidant, analgesic and antipyretic activities in in vitro experiments and in vivo animal models. The aim of the study was to investigate the protective characteristic of CGA on renal I/R injury. METHODS 24 rats were randomly allocated to three groups (n = 8): Sham, I/R+CGA and I/R groups. CGA was administered intraperitoneally at a dose of 20 mg/kg, 10 min before reperfusion. I/R injury was achieved by clamping the left renal artery for 45 minutes, followed by reperfusion for 4 hours. The left kidneys of the rats were examined for tissue damage by histopathological and biochemical examination. For histological evaluation, EGTI scoring system was used. For biochemical examination total oxidant status, total antioxidant status and oxidative stress index were used. The power analysis indicated that 8 subjects per group would be required to produce 80% chance of achieving statistical significance at p < 0.05 level. The results are expressed as mean ± SD. Mann- Whitney U was performed for statistical analysis. RESULTS Histopathological examination of the tissue damage revealed that all kidneys in the sham group were normal. I-R group had significantly higher histopathological scores than other groups. Histopathological improvement was seen after CGA treatment. TAS, TOS and OSI values of I-R group were significantly higher than sham group (0.88 vs 0.76 (p: 0.004), 13.8 vs 7.04 (p: 0.021) and 0.15 vs 0.09 (p: 0.034), respectively). In CGA treated group TAS, TOS and OSI levels were 0.84, 6.47 and 0.07, respectively. CGA treatment resulted in significant improvement in TOS and OSI parameters. CONCLUSIONS CGA treatment provided marked improvement in renal histology and suppressed oxidative stress. Thus, CGA may have a protective effect in renal tissue against I/R injury.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002726 Chlorogenic Acid A naturally occurring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidative stress in rats. (From J Chromatogr A 1996;741(2):223-31; Biosci Biotechnol Biochem 1996;60(5):765-68). 3-Caffeoylquinic Acid,3 Caffeoylquinic Acid,Acid, 3-Caffeoylquinic,Acid, Chlorogenic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
January 2003, Journal of nephrology,
Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
March 2014, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
December 2020, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica,
Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
May 2007, Regulatory peptides,
Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
January 2012, Kidney & blood pressure research,
Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
April 2023, Journal of medicine and life,
Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
March 2008, Journal of cardiovascular pharmacology,
Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
January 2008, Pharmacological reports : PR,
Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
January 2005, Pharmacological reports : PR,
Tuncay Toprak, and Cagri Akin Sekerci, and Hasan Riza Aydın, and Mehmet Akif Ramazanoglu, and Fatma Demet Arslan, and Banu Isbilen Basok, and Hatice Kucuk, and Huseyin Kocakgol, and Hamit Zafer Aksoy, and Seyhan Sumeyra Asci, and Yılören Tanıdır
January 2019, International journal of preventive medicine,
Copied contents to your clipboard!